CTX-471 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

Washington University School of Medicine1

Indications

Glioblastoma1
Cancer1

St Louis, Missouri1 trial

Safety and Efficacy of CTX-009 With or Without CTX-471 for Recurrent Glioblastoma

Washington University School of Medicine

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.